Skip to main content

Table 4 Validation of de facto drug targets

From: Disease Pathway Cut for Multi-Target drugs

ID

Target proteins

Drug

AD

PSEN1 (HSA:5663)

Begacestat (D08869) /Tarenflurbil (D09010) /Semagacestat (D09377) /Avagacestat (D09869)

T2DM

INSR (HSA:3643)

Insulin (D00085) / etc. 19 insulin related drugs

MEL

MAP2K (HSA:5604)

Cobimetinib (D10405) /Cobimetinib fumarate (D10615)

PC

AR (HSA:367)

Testosterone (D00075) /Flutamide (D00586) /Bicalutamide (D00961) /Nilutamide (D00965) /Enzalutamide (D10218)